Female Sex Drive Booster Addyi Is Back, But Will Second Time Around Be Different?

Sprout Pharmaceuticals Inc. is relaunching Addyi (flibanserin), the first-ever approved drug for low libido, or hypoactive sexual desire disorder (HSDD), which affects up to six million pre-menopausal women in the U.S. HSDD is characterized by persistent low sexual desire and emotional distress that are not attributable to an existing medical condition or relationship issue.